$0.03
0.00 (-8.57%)
deCODE genetics, Inc. (DCGN)
CAPS Rating:
A biopharmaceutical company applying its discoveries in human genetics to develop drugs and diagnostics for common diseases.
A biopharmaceutical company applying its discoveries in human genetics to develop drugs and diagnostics for common diseases.